{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:08:17Z","timestamp":1792721297757,"version":"4.5.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T00:00:00Z","timestamp":1334188800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1002649","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T21:07:27Z","timestamp":1334264847000},"page":"e1002649","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":80,"title":["In Vivo Suppression of HIV by Antigen Specific T Cells Derived from Engineered Hematopoietic Stem Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Scott G.","family":"Kitchen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard R.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Bristol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Rezek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Aguilera-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arumugam","family":"Balamurugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto O.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome A.","family":"Zack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.","volume":"68","author":"RA Koup","year":"1994","journal-title":"J Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1126\/science.279.5359.2103","article-title":"Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.","volume":"279","author":"GS Ogg","year":"1998","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.","volume":"68","author":"P Borrow","year":"1994","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.it.2009.12.003","article-title":"Lessons learned from natural infection: focusing on the design of protective T cell vaccines for HIV\/AIDS.","volume":"31","author":"JD Ahlers","year":"2010","journal-title":"Trends Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection.","volume":"206","author":"N Goonetilleke","year":"2009","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1128\/JVI.00182-09","article-title":"Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells.","volume":"83","author":"H Streeck","year":"2009","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1126\/science.1168676","article-title":"Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection.","volume":"323","author":"Q Li","year":"2009","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nri2357","article-title":"Impact of MHC class I diversity on immune control of immunodeficiency virus replication.","volume":"8","author":"PJ Goulder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/JVI.73.1.797-800.1999","article-title":"Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.","volume":"73","author":"GS Ogg","year":"1999","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1128\/JVI.75.14.6508-6516.2001","article-title":"Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.","volume":"75","author":"JP Casazza","year":"2001","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e8208","DOI":"10.1371\/journal.pone.0008208","article-title":"Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.","volume":"4","author":"SG Kitchen","year":"2009","journal-title":"PLoS ONE"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1128\/JVI.02207-08","article-title":"Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice.","volume":"83","author":"DM Brainard","year":"2009","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e8829","DOI":"10.1371\/journal.pone.0008829","article-title":"Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice.","volume":"5","author":"PW Denton","year":"2010","journal-title":"PLoS ONE"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pmed.0050016","article-title":"Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.","volume":"5","author":"PW Denton","year":"2008","journal-title":"PLoS Med"},{"key":"ref15","first-page":"149","article-title":"Functional and phenotypic characterization of the humanized BLT mouse model.","volume":"324","author":"AK Wege","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2009-04-215855","article-title":"A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.","volume":"115","author":"S Shimizu","year":"2010","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.immunol.24.021605.090612","article-title":"Development of human lymphoid cells.","volume":"24","author":"B Blom","year":"2006","journal-title":"Annual Rev Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jviromet.2005.10.016","article-title":"A novel small reporter gene and HIV-1 fitness assay.","volume":"133","author":"A Ali","year":"2006","journal-title":"J Virol Methods"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nature08237","article-title":"Architecture and secondary structure of an entire HIV-1 RNA genome.","volume":"460","author":"JM Watts","year":"2009","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2003-02-0420","article-title":"Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions.","volume":"102","author":"N Rufer","year":"2003","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.4049\/jimmunol.178.7.4112","article-title":"Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.","volume":"178","author":"P Romero","year":"2007","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"E1408","DOI":"10.1073\/pnas.1115050108","article-title":"Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.","volume":"108","author":"DN Vatakis","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design.","volume":"8","author":"RA Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cell.2009.06.036","article-title":"Redefining chronic viral infection.","volume":"138","author":"HW Virgin","year":"2009","journal-title":"Cell"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.","volume":"205","author":"RB Jones","year":"2008","journal-title":"J Exp Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11904-010-0066-0","article-title":"Revisiting immune exhaustion during HIV infection.","volume":"8","author":"A Khaitan","year":"2011","journal-title":"Cur HIV\/AIDS Rep"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1371\/journal.pbio.0040090","article-title":"Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo.","volume":"4","author":"B Asquith","year":"2006","journal-title":"PLoS Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.192.1.63","article-title":"HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.","volume":"192","author":"V Appay","year":"2000","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO;2-M","article-title":"High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.","volume":"31","author":"S Kostense","year":"2001","journal-title":"Eur J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1000981","DOI":"10.1371\/journal.pcbi.1000981","article-title":"Quantifying the impact of human immunodeficiency virus-1 escape from cytotoxic T-lymphocytes.","volume":"6","author":"UD Kadolsky","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.0401500101","article-title":"CD4 on CD8+ T cells directly enhances effector function and is a target for HIV infection.","volume":"101","author":"SG Kitchen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1182\/blood-2009-02-202481","article-title":"Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface.","volume":"114","author":"A Zloza","year":"2009","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1128\/JVI.78.3.1160-1168.2004","article-title":"T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.","volume":"78","author":"JM Brenchley","year":"2004","journal-title":"J Virol"},{"key":"ref34","first-page":"74","article-title":"The SCID-hu mouse: a small animal model for the analysis of human hematolymphoid differentiation and function.","volume":"9","author":"JM McCune","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.virol.2011.05.013","article-title":"Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2R[gamma]\u2212\/\u2212 (NSG) BLT mice.","volume":"417","author":"CA Stoddart","year":"2011","journal-title":"Virology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1742-4690-8-65","article-title":"The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment.","volume":"8","author":"BK Berges","year":"2011","journal-title":"Retrovirology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.4049\/jimmunol.1000438","article-title":"CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice.","volume":"184","author":"S Gorantla","year":"2010","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.4049\/jimmunol.177.9.6548","article-title":"Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes.","volume":"177","author":"LA Johnson","year":"2006","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/hum.2005.16.457","article-title":"Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.","volume":"16","author":"MS Hughes","year":"2005","journal-title":"Hum Gene Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4049\/jimmunol.163.1.507","article-title":"Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.","volume":"163","author":"TM Clay","year":"1999","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1128\/JVI.01812-07","article-title":"Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.","volume":"82","author":"A Joseph","year":"2008","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.2174\/092986706778521959","article-title":"Engineered T cell receptors and their potential in molecular medicine.","volume":"13","author":"JJ Miles","year":"2006","journal-title":"Curr Med Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"8207","DOI":"10.1128\/JVI.74.17.8207-8212.2000","article-title":"Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes.","volume":"74","author":"LJ Cooper","year":"2000","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.4049\/jimmunol.171.6.3287","article-title":"High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.","volume":"171","author":"RA Morgan","year":"2003","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.","volume":"3","author":"M Kalos","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia.","volume":"365","author":"DL Porter","year":"2011","journal-title":"New Engl J Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes.","volume":"314","author":"RA Morgan","year":"2006","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"E1408","DOI":"10.1073\/pnas.1115050108","article-title":"Anti-tumor activity from antigen specific CD8 T cells generated from genetically engineered human hematopoietic stem cells.","volume":"108","author":"DN Vatakis","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2010.12.039","article-title":"Stem cell-based anti-HIV gene therapy.","volume":"411","author":"SG Kitchen","year":"2011","journal-title":"Virology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1663","article-title":"Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.","volume":"28","author":"N Holt","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1182\/blood-2009-10-251124","article-title":"Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies.","volume":"115","author":"C Alanio","year":"2010","journal-title":"Blood"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/25374","article-title":"Changes in thymic output with age and during the treatment of HIV infection.","volume":"396","author":"DC Douek","year":"1999","journal-title":"Nature"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1074-7613(00)80056-4","article-title":"Generation of functional thymocytes in the human adult.","volume":"10","author":"BD Jamieson","year":"1999","journal-title":"Immunity"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nm.1932","article-title":"Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.","volume":"15","author":"R Mitsuyasu","year":"2009","journal-title":"Nat Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e1000365","DOI":"10.1371\/journal.ppat.1000365","article-title":"Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.","volume":"5","author":"RM Troyer","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e1000103","DOI":"10.1371\/journal.pcbi.1000103","article-title":"Dynamics of Immune Escape during HIV\/SIV Infection.","volume":"4","author":"CL Althaus","year":"2008","journal-title":"PLoS Comput Biol"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1002649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T23:24:25Z","timestamp":1687389865000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1002649"}},"subtitle":[],"editor":[{"given":"Daniel C.","family":"Douek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,12]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1002649","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,12]]}}}